Clinical risk factors for complicated disease: how reliable are they?
about
Inflammatory bowel disease surgery in the biologic eraEstimates of Disease Course in Inflammatory Bowel Disease Using Administrative Data: A Population-level Study.Clinical markers of Crohn's disease severity and their association with opiate use.Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel diseaseFirst-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Advances in the medical management of paediatric IBD.Targeting TNF-α for the treatment of inflammatory bowel disease.Long-term safety of immunomodulators in pediatric inflammatory diseases.Adalimumab for the treatment of pediatric Crohn's disease.Immunomodulators for the treatment of Crohn's disease in adults: optimal use and prospects for future drug treatments.Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.Lower extremity necrotizing fasciitis: A unique initial presentation of Crohn's disease.Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients.Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.New Trends in Inflammatory Bowel Disease.Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
P2860
Q26745627-16494B69-B745-4EC1-B2F7-6A8A982E95BFQ31141014-EE864694-7B02-491D-BECE-767DF533A329Q34443893-E215AB0F-3200-4E24-9ED2-5902F4E2C932Q37719806-7F0D0D2E-EED3-4B02-BAC8-7BF45EB0FBB2Q38086355-03B86DE9-F214-4798-ABC8-7EA8EF8514FFQ38130044-13FCDB7A-2E52-4511-AE7C-2C1643C68557Q38160905-086DC995-2001-4F92-A1E2-40518E2DA1EFQ38232338-2114F3A3-7FDE-430D-B8E8-A5799A51577BQ38554433-24870750-CECB-4A37-BA7A-5A44B20B9262Q38743666-DC7DA968-698B-455B-A2C0-DAF068F03BACQ38752119-151722F1-7CBE-42DF-AC78-268B52AEF1E1Q38987132-29CCBAD4-5EB7-4BC1-B506-204BC235B6E2Q39046581-0DA66D60-5993-476B-8A89-D1F52C7E10C3Q39114030-CEDB4B6C-3A03-4E91-9EE8-82051A6AB57BQ50578123-838EE4AA-A7E0-4A3D-AB7D-65B6A70166E0Q50979274-31EF5650-4081-445E-88BD-08150F3C6597Q51026199-E2091AF8-45A1-45F2-BB6F-A4D396034EB6Q57212918-0DBE7F98-03D4-4677-B0C9-A25C94525464
P2860
Clinical risk factors for complicated disease: how reliable are they?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical risk factors for complicated disease: how reliable are they?
@en
type
label
Clinical risk factors for complicated disease: how reliable are they?
@en
prefLabel
Clinical risk factors for complicated disease: how reliable are they?
@en
P2860
P356
P1433
P1476
Clinical risk factors for complicated disease: how reliable are they?
@en
P2093
Camille Zallot
P2860
P356
10.1159/000342608
P478
30 Suppl 3
P577
2012-01-01T00:00:00Z